BioCentury
ARTICLE | Clinical News

NicVax: Phase IIb started

November 2, 2009 8:00 AM UTC

Investigators began a double-blind, Dutch Phase IIb trial to evaluate Chantix varenicline in combination with NicVAx or placebo in 600 patients. Chantix is marketed by Pfizer Inc. (NYSE:PFE, New Yor...